About
• CFA, Level Three Candidate; CAIA; CMT, Level Two Candidate
• Strong comprehension…
• Strong comprehension…
Activity
6K followers
-
Christopher Hunt shared thisLiberty Health Sciences Expands National Footprint with Controlling Interest in Massachusetts-based Cultivation and Dispensary OperationLiberty Health Sciences Expands National Footprint with Controlling Interest in Massachusetts-based Cultivation and Dispensary Operation
-
Christopher Hunt shared thisOpinion: One chart shows all the bubbles that are about to popOpinion: One chart shows all the bubbles that are about to pop
Christopher Hunt commented on a post
8y
I would be interested in using Paragon Coin for our portfolio companies.
chris@huntequitygroup.com
-
Christopher Hunt liked thisChristopher Hunt liked thisI’d hire these four 20-year-olds over a Goldman banker any day. Last week I judged a stock pitch competition. Four students from Cal State Fullerton pitched Cathay General Bancorp (CATY). Not Wharton. Not a target school. Not even close. 10 minutes. No notes. Flawless. They cold called a competitor’s CFO and got a meeting. They scraped thousands of Glassdoor reviews. They called a dozen industry executives and consultants. Then they got grilled for 10 minutes. Every question answered with conviction. No hedging. No filler. They knew their thesis, they knew what broke it, and they defended it like it was their money on the line. I scored them 98 out of 100. They beat UCLA, USC, and every other team in the competition. They’re advancing to the next round. These are 20-year-olds at a school that doesn’t show up on any bulge bracket firm’s recruiting list. No pedigree. And they sounded more like investors than 95% of the buy-side candidates I’ve seen come out of top MBA programs and bulge bracket banks. The difference? They did the work that actually matters. Not the model. Not the slides. The primary research. The channel checks. The real conversations with real people who actually know the business. Maybe pedigree gets you in the room. This is what gets you a seat on the buy-side. If you’re a PM or know of someone looking for junior analysts who already think like investors — I’d start with these four. Eamon Andrew Helding | Karhan Camurdan | Samantha Santonil | Mateo García CFA Society Los Angeles
-
Christopher Hunt liked thisChristopher Hunt liked thisWarmest congratulations to all my Deutsche Bank Finance colleagues who are celebrating their promotions today! 2022 was a demanding year in many ways, and promotion in this environment is an outstanding achievement. Well done all! Special thanks, in addition, to all the leaders and team-mates across Finance who inspired and supported our newly-promoted colleagues on this journey. You made many vital contributions to their success, and that is much appreciated. For me, today is a reminder of the excellent talent we have in Finance at Deutsche Bank. I’m delighted we can celebrate that talent on this special day.
-
Christopher Hunt liked thisNice summary thank youChristopher Hunt liked thisList of market outlooks for 2023 (Credit: Anthony Cheung) Goldman Sachs https://lnkd.in/eKzF_2K4 J.P. Morgan https://lnkd.in/eHb6-622 Morgan Stanley https://lnkd.in/e2nAMjmM Bank of America https://lnkd.in/e8XFD8TW BlackRock https://lnkd.in/eYxCBRGj HSBC https://lnkd.in/eNfBiJvH Barclays https://lnkd.in/eRT4dsFY. NatWest https://lnkd.in/euftbUw6 Citi https://lnkd.in/eXwA-Y4X UBS https://lnkd.in/exudCU6V Credit Suisse https://lnkd.in/e4CEK5NZ BNP Paribas https://lnkd.in/ec4hWEdm Deutsche Bank https://lnkd.in/eAWCSV_7 ING https://lnkd.in/eNpdmVH8 Apollo Global Management, Inc. https://lnkd.in/ewwq_62M Wells Fargo https://lnkd.in/euMkQnKE BNY Mellon https://lnkd.in/ezMfVgND Fidelity International https://lnkd.in/eJwK6tVx Lazard https://lnkd.in/eku-xhqp
-
Christopher Hunt liked thisChristopher Hunt liked thisThey say, that no news is good news - but not in the case of Canopy Growth. You see, there really was no news yesterday - and yet, the stock dropped over 10% to a new 52 week low - in fact, it hasn't been this low since 2016, when it was just a small medical cannabis company, promising global domination. Can it go any lower? Of course - in fact, I can't see why it won't. Because, I cannot see any good news coming out of this company (unless they clean out the entire c-suite). I expect continued facility closings and employee firings and financial losses - STZ might toss some more cash on the dumpster fire, in order to keep it going, but, come on - this thing is going to zero - I know it, you know it, and they know it.
-
Christopher Hunt liked thisChristopher Hunt liked thisSo what’s next in Costa Rica? NHA was happy to support the most important and inaugural event “Cannabis Science and Technology Conference” hosted by Cree Crawford of Ionization Labs and, Costa Rican Government contractor and Rocco COO Dan O’Bryan. I was happy to bring the US Keynote and sharing our experience so to help with hemp regulations in this nation. Not surprising this event was perfectly timed as Dan and Cree have been working hard for months, have developed the relationships with the legislators and now have an ear on the pulse of what’s happening in that nation. On the opening day of the conference, President Alvarado authorized parts of the Cannabis legislation sent to his desk. Save your money. There is no need to learn from others when Cree and Dan can deliver in Costa Rica. Here’s an excerpt from a recent media report on the subject. “Provisions proposed to govern Costa Rica’s industrial hemp will remain in place, according to changes requested by President Carlos Alvarado. Alvarado late last week partially vetoed a proposed cannabis law that had passed the Costa Rican Legislative Assembly on a slim 29-28 vote earlier this month. The proposed law covers cultivation, harvesting, processing, storage and transport of medical marijuana and hemp, and would make all hemp components legal for food and industrial purposes. Alvarado said he is sending the bill back to the Legislative Assembly with recommendations for changes that would eliminate three provisions related to “self-cultivation and self-consumption” of marijuana for medical purposes. Despite rejecting the legalization of controlled home growing of marijuana by medical patients, Alvarado said he “categorically” supports regulated medical cannabis. For ‘economic recovery’ “And I also support industrial hemp, because it will help agricultural production and economic recovery. Let’s make this very clear: I agree with all those objectives and I want to be able to sign that law,” Alvarado said. The law will allow Costa Rican authorities to grant licenses for the production and industrialization of cannabis for medical or therapeutic purposes. Alvarado’s pledge Alvarado said he intends to get the law on the books before his term ends in May. The president may not stand for re-election in the general elections set for next Sunday, Feb. 6. as Costa Rican presidents may not serve consecutive four-year terms. Some stakeholders have called for establishing a full 1.0% THC as the line delineating hemp from marijuana, which would make CBD production more efficient and reduce the threat of farmers’ crops going “hot,” or over that limit. No such provision is in the law, which indicates that THC limits and other guidelines would be set outside of legislation. #Creecrawford #DanObryan #nationalhempassociation #HempCanHelp #TakeHempSeriously
-
Christopher Hunt liked thisChristopher Hunt liked thisI discussed the weekly newsletter we will be publishing tomorrow morning about the #cannabis industry, which includes a very bold prediction
-
Christopher Hunt liked thisThrilled to announce our new $17M lease facility for a leading multi-state operator. Proud of the XS Financial, Inc team as we continue to expand our portfolio with best-in-class operators.Christopher Hunt liked thisXS Financial Provides $17 Million Equipment Lease Facility to Support Large Multi-State Cannabis Operator's Expansion.
-
Christopher Hunt liked thisChristopher Hunt liked thisIt's been a pleasure and an honor to serve on the Axonius Board in support of an amazing group of entrepreneurs (Dean Sysman, Ofri Shur & Avidor Bartov) & Executives (Nathan Burke, Joseph Hoban, Lenny Zeltser & many more). I'm truly grateful for the opportunity for YL Ventures to support this team on their #cybersecurity journey since their #seed round in 2017 - and also lucky to have learned so much from a top tier group of operators, as well as from an amazing group of fellow investors (including Amit Karp of Bessemer Venture Partners, Mackey Craven of OpenView, and Arsham Memarzadeh & Tal Morgenstern of Lightspeed Venture Partners) & board members (Anne DelSanto). From the company's earliest days, Dean's vision for a game-changing platform has been crystal clear & over time that vision has translated into incredible velocity. As Axonius moves on to the next stage of their growth, we'll be excited to see where they go from here. The sky is the limit, no doubt! https://lnkd.in/eDsZPwYYL Ventures sells its stake in cybersecurity unicorn Axonius for $270M | TechCrunchYL Ventures sells its stake in cybersecurity unicorn Axonius for $270M | TechCrunch
Experience & Education
Licenses & Certifications
Honors & Awards
-
All-American
-
All-American Tight End
-
John E. Kelly Offensive Player Of The Year
-
Languages
-
English
Native or bilingual proficiency
-
French
Limited working proficiency
Other similar profiles
Explore more posts
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content